Rivaara Labs

Rivaara Labs Rivaara Labs is an exclusive lab chain for molecular diagnostics in India.

🌍 On World AIDS Day let’s close the gap between infection and diagnosis.With 39.9 million people living with HIV — and 1...
01/12/2025

🌍 On World AIDS Day let’s close the gap between infection and diagnosis.
With 39.9 million people living with HIV — and 1 in 5 unaware of their status — timely testing is crucial. This reminds us that awareness and early diagnosis save lives.
Accurate molecular diagnostics remain a key pillar in identifying infections sooner and improving patient outcomes.
At RIVAARA Labs, we stand with clinicians, caregivers, and communities working to end the stigma and strengthen early detection.
Act today. Test early. Stay informed.

World AMR Week highlights one undeniable truth - diagnostics are the first step in defeating AMR.Our AMR Panels enable e...
24/11/2025

World AMR Week highlights one undeniable truth - diagnostics are the first step in defeating AMR.

Our AMR Panels enable early detection, targeted therapy, improved stewardship, and ultimately, better outcomes.

At Rivaara Labs, we continue our commitment to rapid, precise, and reliable AMR testing.

Act Now, Protect Our Present, Secure Our Future.

22/11/2025

AMR is one of India’s fastest-growing healthcare threats. Its burden is rising, and so is the urgency to act.

In this video, Dr.Girish Gaur (Chief Operating Officer) Rivaara Labs Pvt Ltd., talks about the growing challenges in antimicrobial resistance and the role of molecular diagnostics in detecting resistance early, which is guiding therapy, improving patient outcomes. and targeted decision-making.

At Rivaara Labs, we’re committed to empowering clinicians with better diagnostics for better decisions
Better diagnostics today means stronger patient outcomes tomorrow.
Act Now, Protect Our Present, Secure Our Future.

Carbapenems are failing. Cephalosporins are failing. Even colistin is showing cracks.AMR in India is escalating - and so...
20/11/2025

Carbapenems are failing. Cephalosporins are failing. Even colistin is showing cracks.
AMR in India is escalating - and so must our response.
Act Now, Protect Our Present, Secure Our Future.
Better diagnostics. Better decisions. Better outcomes.


18/11/2025

Antimicrobial Resistance (AMR) is no longer a distant threat - it's a present and accelerating crisis.

From rising superbugs to delayed diagnostics and limited treatment options, clinicians face unprecedented challenges in delivering effective care.

Here is some information of global and Indian AMR landscape, the clinical impact, and what we must do now to protect the future of medicine.

Stronger diagnostics, stewardship, and One Health action are essential. Let's raise awareness. Let's act with purpose.


Antimicrobial Resistance (AMR) is an invisible threat that cannot be seen but is continuously growingIt’s reshaping how ...
17/11/2025

Antimicrobial Resistance (AMR) is an invisible threat that cannot be seen but is continuously growing
It’s reshaping how we diagnose, treat, and manage infections.
AMR is rising quietly, turning routine infections into life-threatening challenges.
It is silently advancing—impacting outcomes, increasing complexity, and challenging the treatment.
The silent threat demands urgent attention.

Are we ready to act on it?
This World AMR Awareness Week,
Stay tuned with us as we are with you to fight with this silent storm.
Let’s break the silence together





Something alarming is silently growing around us.The threat is silent but the impact won't be.It’s time to question our ...
16/11/2025

Something alarming is silently growing around us.
The threat is silent but the impact won't be.
It’s time to question our preparedness.

Are we ready to confront it?
Coming soon: World AMR Week.




We are delighted to share that Dr. Girish Gaur (Associate director, Operations & National Lab head) was invited as a Ke...
08/11/2025

We are delighted to share that Dr. Girish Gaur (Associate director, Operations & National Lab head) was invited as a Keynote Speaker at the International Conference on BIOINNOVATE 2025: Bridging Science and Society for Sustainable Development Goals, organized by Lovely Professional University (LPU).

Dr. Gaur delivered an inspiring session on “Harnessing the Power of Molecular Biology & Genetic Engineering for a Better Tomorrow,” offering valuable insights into the evolving landscape of molecular diagnostics and the transformative role of innovation in healthcare. He emphasized how modern molecular tools and genetic advancements are revolutionizing diagnostics and biotechnology — aligning with the UN Sustainable Development Goals (SDGs) to create a healthier and more sustainable future.

We extend our heartfelt gratitude to the organizers for providing a platform that brings together brilliant minds from academia, industry, and clinical practice — driving conversations that bridge science, strategy, and patient-centred impact that fosters collaboration between academia and industry, driving scientific innovation for a sustainable tomorrow.

27/10/2025

SPOT SEPSIS STOP SEPSIS
How can molecular diagnostics change the way we fight sepsis?
Hear from Dr. Gunjan Chanchalani as she shares her perspective on faster, targeted treatment decisions that are redefining infection management in critical care.

At Rivaara, we are proud to support clinicians with advanced molecular solutions for faster and more precise infection management.

See beyond traditional culture.Some pathogens won’t grow. Others take days.SeptiQuik™ DR detects AMR genes (NDM, OXA, KP...
11/10/2025

See beyond traditional culture.
Some pathogens won’t grow. Others take days.
SeptiQuik™ DR detects AMR genes (NDM, OXA, KPC, VIM, mecA & more) directly from blood or body fluids - helping your team act faster and smarter.

Learn More: https://rivaaralabs.com/septiquik-panels/

Your ICU deserves molecular speed. ⚡From blood to actionable results within hours — SeptiQuik™ panels empower early, evi...
10/10/2025

Your ICU deserves molecular speed. ⚡
From blood to actionable results within hours — SeptiQuik™ panels empower early, evidence-based therapy when every minute matters.

Accelerating sepsis diagnosis in pediatrics with SeptiQuik™ - delivering molecular insights from just 1–5 mL of blood. P...
10/10/2025

Accelerating sepsis diagnosis in pediatrics with SeptiQuik™ - delivering molecular insights from just 1–5 mL of blood. Precision that saves time and lives.

Learn More: https://rivaaralabs.com/septiquik-panels/

Address

17th Floor, Hoechst House, Nariman Point
Mumbai
400021

Telephone

+919301000083

Website

Alerts

Be the first to know and let us send you an email when Rivaara Labs posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Rivaara Labs:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category